Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(3aR,8bR)-8b-Hydroxy-6,8-dimethoxy-3a-(4-methoxy-phenyl)-3-phenyl-2,3,3a,8b-tetrahydro-benzo[b]cyclopenta[d]furan-1-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

117828-45-2

Post Buying Request

117828-45-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

117828-45-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 117828-45-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,8,2 and 8 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 117828-45:
(8*1)+(7*1)+(6*7)+(5*8)+(4*2)+(3*8)+(2*4)+(1*5)=142
142 % 10 = 2
So 117828-45-2 is a valid CAS Registry Number.

117828-45-2Relevant articles and documents

COMPOSITIONS AND METHODS FOR INHIBITING VIRAL INFECTION

-

Paragraph 0020, (2020/05/06)

Described herein are compounds, agents, compositions, and methods related to the treatment of a viral infection (e.g., Hepatitis C viral infection). In particular, the compounds, agents, compositions, and methods described herein inhibit viral entry into a target cell.

Chemical Synthesis Enables Structural Reengineering of Aglaroxin C Leading to Inhibition Bias for Hepatitis C Viral Infection

Zhang, Wenhan,Liu, Shufeng,Maiga, Rayelle I.,Pelletier, Jerry,Brown, Lauren E.,Wang, Tony T.,Porco, John A.

, p. 1312 - 1323 (2019/01/21)

As a unique rocaglate (flavagline) natural product, aglaroxin C displays intriguing biological activity by inhibiting hepatitis C viral entry. To further elucidate structure-activity relationships and diversify the pyrimidinone scaffold, we report a concise synthesis of aglaroxin C utilizing a highly regioselective pyrimidinone condensation. We have prepared more than 40 aglaroxin C analogues utilizing various amidine condensation partners. Through biological evaluation of analogues, we have discovered two lead compounds, CMLD012043 and CMLD012044, which show preferential bias for the inhibition of hepatitis C viral entry vs translation inhibition. Overall, the study demonstrates the power of chemical synthesis to produce natural product variants with both target inhibition bias and improved therapeutic indexes.

Synthetic analogue of rocaglaol displays a potent and selective cytotoxicity in cancer cells: Involvement of apoptosis inducing factor and caspase-12

Thuaud, Frédéric,Bernard, Yohann,Turkeri, Gulen,Dirr, Ronan,Aubert, Geneviéve,Cresteil, Thierry,Baguet, Aurélie,Tomasetto, Catherine,Svitkin, Yuri,Sonenberg, Nahum,Nebigil, Canan G.,Désaubry, Laurent

supporting information; experimental part, p. 5176 - 5187 (2010/03/02)

Flavaglines constitute a family of natural anticancer compounds. We present here 3 (FL3), the first synthetic flavagline that inhibits cell proliferation and viability (IC50≈1 nM) at lower doses than did the parent compound, racemic rocaglaol.

Total synthesis of (±)-rocaglamide and some aryl analogues

Dobler, Markus R,Bruce, Ian,Cederbaum, Fredrik,Cooke, Nigel G,Diorazio, Louis J,Hall, Roger G,Irving, Ed

, p. 8281 - 8284 (2007/10/03)

The insecticidal activity found for rocaglamide and its congeners, prompted us to establish a short and efficient synthesis of the natural product and some synthetic 'halo-aryl' analogues. Pd-catalysed cross-coupling reactions of the bromo analogue were then explored in order to gain a suitable access to a broad range of unnatural analogues. The key step of our approach is a keto-aldehyde acyloin ring-closure followed by a Stiles carboxylation.

Synthesis of the Novel Anti-leukaemic Tetrahydrocyclopentabenzofuran, Rocaglamide and Related Synthetic Studies

Davey, Andrew E.,Schaeffer, Marcel J.,Taylor, Richard J. K.

, p. 2657 - 2666 (2007/10/02)

Two approaches to the rocaglamide tricyclic skeleton are described.The first, which employs an unusual dithianyl anion to carbonyl addition reaction, provides access to α-phenyl rocaglamide analogues.The second route involves an intramolecular keto aldehyde pinacolic coupling in the key step and can be used for the preparation of a whole range of rocaglamide analogues possessing both α- and β-phenyl substituents.A total synthesis of rocaglamide, in racemic form, is described using this second approach.The synthetic route commences with phloroglucinol, an inexpensive and readily-available starting material, and takes only 8/9 steps giving an overall yield > 6percent.The synthesis of 1-epi-rocaglamide 29b is also described.

A Synthetic Approach to Rocaglamide via Reductive Cyclization of δ-Keto Nitriles

Kraus, George A.,Sy, James O.

, p. 77 - 83 (2007/10/02)

The anticancer agent rocaglamide contains a novel bicyclooctanol structure.The approach to this molecule involved the preparation of a hydroxy ketone intermediate via a samarium-mediated cyclization.This ketone was then converted into an excellent

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 117828-45-2
  • ©2008 LookChem.com,License:ICP NO.:Zhejiang16009103 complaints:service@lookchem.com
  • [Hangzhou]86-0571-87562588,87562578,87562573 Our Legal adviser: Lawyer